Jorge Omar Yanez-Cuna

Selbstständig, Consultant, Stealth Biotech
Zurich, Switzerland

Skills

Project Management
Gene Therapy
Molecular biology
Genomics
Machine Learning
Research and Development
Competitive Intelligence
Management
Biotechnology
IP
Bioinformatics
Product Development
Technology
Data Analysis
Intellectual Property
DNA
Cell Biology
Gene expression
Preclinical Study
Team leadership
Research
Customer Relationship Management
Strategic planning
Strategic management
Resource Management
Genetics
Sequencing
MS Office
English Language
Biology
Coaching
Agile Development
innovative
Efficiency
Team work
Problem Solving
Leadership skills
results-oriented
Communication skills
attention to detail
Presentation skills
Teamwork
Critical thinking
Logical thinking
Conceptual thinking
strong interpersonal skills
Leadership
Biologics
Change Management
Process Optimization

Timeline

Professional experience for Jorge Omar Yanez-Cuna

  • Current 1 year and 6 months, since Apr 2025

    Consultant

    Stealth Biotech

  • Current 4 years and 11 months, since Nov 2021

    Associated Director / Head of R&D

    Anjarium Biosciences AG

    Led R&D for a rapidly evolving biotech developing non-viral gene delivery and novel DNA technologies. The latter became the core value driver behind its acquisition by National Resilience. I left the company following the relocation of the technology and operations to the USA. - Identified poor translation between in vitro, in vivo models as a critical blocker and designed a multi-omics pipeline to screen 20–40 LNP formulations directly in NHPs. - Built a multidisciplinary team of 10+ scientists.

  • 2 years and 10 months, Jan 2019 - Oct 2021

    Principal Scientist

    Asklepios BioPharmaceutical Inc (AskBio)

    Senior scientific role within a pioneering gene therapy (rAAV) company. Directly contributed to two indications now in clinical trials and to AskBio’s acquisition by Bayer for $2Bn. - Led the design and development of AAV regulatory elements using AI/ML, bioinformatics and multi-omics to support multiple programmes. - Owned preclinical design and execution for muscle and cardiac gene therapies, with additional contributions to liver and CNS programmes.

  • 1 year and 9 months, Apr 2017 - Dec 2018

    Senior Research Scientist

    Synpromics LTD

    Joined a growing biotech to build the scientific pipeline underpinning its gene therapy partnerships and commercial strategy. The platform formed the scientific foundation for Synpromics’ acquisition by AskBio. - Built the core scientific pipeline integrating AI/ML, multi-omics and preclinical validation to design synthetic promoters for gene therapy. - Delivered nine client programmes across multiple tissues, maintaining alignment with partners such as BioMarin, AGTC, and Solid Biosciences.

  • 2 years and 9 months, Jul 2014 - Mar 2017

    Postdoctoral Researcher

    Netherlands Cancer Institute (NKI)

    Working with Bas van Steensel, focusing on gene regulation and multi-omics technology development in a world-class cancer research institute. - Established high-throughput multi-omics screening assays using CRISPR-based and transposon technologies. - Published multiple peer-reviewed papers, including work in Cell, advancing understanding of chromatin organisation.

  • 5 years, May 2009 - Apr 2014

    PhD Candidate

    Research Institute of Molecular Pathology (IMP)

    Working with Alexander Stark, pioneered early applications of AI/ML to decode gene regulation using multi-omics data, contributing to the development of STARR-seq and publishing in Nature. - Awarded VBC PhD Award for Outstanding Thesis.

Languages

  • Spanish

    C2 (Expert / native speaker)

  • English

    C1 (Fluent)

  • French

    B1-B2 (Good)

  • German

    B1-B2 (Good)

XING – The jobs network

  • Over 1 million jobs

    Find just the right job for you on XING.

  • Job offers just for you

    Get found by employers and over 20,000 recruiters.

  • 21 million members

    Connect with new people and gather inspiration to boost your working life.

  • Free membership

    Basic membership is free, but the opportunities are priceless.

Browse over 21 million XING members